Literature DB >> 15803279

An in vivo study of a bone grafting material consisting of hydroxyapatite and reconstituted collagen.

Fu-Yin Hsu1, Shiao-Wen Tsai, Chen-Wen Lan, Yng-Jiin Wang.   

Abstract

This study aims to evaluate the performance of our recently developed microspheres of hydroxyapatite/reconstituted collagen as a bone grafting material. The microspheres were fabricated into a circular disc and implanted in a pre-drilled hole in a rat's calvaria. The bone tissue had regenerated and grown into the disc bone graft 4 weeks following implantation. After 16 weeks of implantation, the regenerated bone had integrated with the remaining material and made close contact with it. The disc had been completely absorbed with almost no visible bone graft left after 24 weeks of implantation. In contrast, a hydroxyapatite disc still remained intact on the 24th week after implantation. These results suggested that the hydroxyapatite/reconstituted collagen microsphere can be used as an excellent bone grafting material.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15803279     DOI: 10.1007/s10856-005-0633-x

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  16 in total

1.  Microspheres of hydroxyapatite/reconstituted collagen as supports for osteoblast cell growth.

Authors:  F Y Hsu; S C Chueh; Y J Wang
Journal:  Biomaterials       Date:  1999-10       Impact factor: 12.479

2.  The collagen-containing alginate/poly(L-lysine)/alginate microcapsules.

Authors:  F Y Hsu; S W Tsai; F F Wang; Y J Wang
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2000-03

3.  Tetracycline bone labeling.

Authors:  H M FROST; A R VILLANUEVA; H ROTH; S STANISAVLJEVIC
Journal:  J New Drugs       Date:  1961 Sep-Oct

4.  Bone localization of the tetracyclines.

Authors:  R A MILCH; D P RALL; J E TOBIE
Journal:  J Natl Cancer Inst       Date:  1957-07       Impact factor: 13.506

5.  Application of stains-all for demarcation of cement lines in methacrylate embedded bone.

Authors:  H E Gruber; P Mekikian
Journal:  Biotech Histochem       Date:  1991       Impact factor: 1.718

6.  In vitro and in vivo studies with collagen/hydroxyapatite implants.

Authors:  H A Marouf; A A Quayle; P Sloan
Journal:  Int J Oral Maxillofac Implants       Date:  1990       Impact factor: 2.804

7.  Preservation of the alveolar ridge with hydroxyapatite-collagen implants in rats.

Authors:  E Hahn; S Sonis; G Gallagher; D Atwood
Journal:  J Prosthet Dent       Date:  1988-12       Impact factor: 3.426

8.  The use of frozen cadaveric allografts in the management of patients with bone tumors of the extremities.

Authors:  H J Mankin; M C Gebhardt; W W Tomford
Journal:  Orthop Clin North Am       Date:  1987-04       Impact factor: 2.472

9.  Effect of hydroxylapatite, tricalcium phosphate, and collagen on the healing of defects in the rat mandible.

Authors:  R Bell; O R Beirne
Journal:  J Oral Maxillofac Surg       Date:  1988-07       Impact factor: 1.895

Review 10.  Synthetic bone graft substitutes.

Authors:  P D Costantino; C D Friedman
Journal:  Otolaryngol Clin North Am       Date:  1994-10       Impact factor: 3.346

View more
  4 in total

1.  Fabrication and characterization of osteogenic function of progenitor cell-laden gelatin microcarriers.

Authors:  Chukwuma E Nweke; Jan P Stegemann
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2021-12-17       Impact factor: 3.368

2.  Free vascularized fibular graft reconstruction of large skeletal defects after tumor resection.

Authors:  William C Eward; Vasileios Kontogeorgakos; Lawrence Scott Levin; Brian E Brigman
Journal:  Clin Orthop Relat Res       Date:  2009-08-22       Impact factor: 4.176

Review 3.  Modular microcarrier technologies for cell-based bone regeneration.

Authors:  Chukwuma E Nweke; Jan P Stegemann
Journal:  J Mater Chem B       Date:  2020-05-14       Impact factor: 6.331

4.  The vascularized fibular graft in the pediatric upper extremity: a durable, biological solution to large oncologic defects.

Authors:  Nicki Zelenski; Brian E Brigman; L Scott Levin; Detlev Erdmann; William C Eward
Journal:  Sarcoma       Date:  2013-10-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.